Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 72 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Colorectal Neoplasms  [Clear All Filters]
2019
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Rallis, G., Koletsa T., Saridaki Z., Manousou K., Koliou G-A., Kostopoulos I., et al. (2019).  Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.. Anticancer Res. 39(4), 2129-2138.
GlobalSurg Collaborative (2019).  Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.. BJS Open. 3(3), 403-414.
Paramythiotis, D., Goulas P., Moysidis M., Karakatsanis A., Tzioufa-Asimakopoulou V., Sotiriou S., et al. (2019).  Metachronous Ovarian Metastases in a Patient with Primary Colorectal Cancer. A Case Report and Review of the Literature.. Am J Case Rep. 20, 1515-1520.
Kotoula, V., Fostira F., & Fountzilas E. (2019).  Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis.. JAMA Oncol. 5(5), 740-741.
2018
Tsalis, K., Ioannidis O., Cheva A., Savvala N. Antigoni, Antoniou N., Parpoudi S., et al. (2018).  A 20-year single center experience in the surgical treatment of colorectal liver metastasis.. J BUON. 23(6), 1640-1647.
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
Mastrokostas, A., Gavana M., Gkrizioti M., Smyrnakis E., Cholongitas E., Benos A., et al. (2018).  Discrepancies and misconceptions of perceived colorectal cancer screening barriers between primary health professionals and unscreened population. A comparative study in Greece.. J BUON. 23(7), 67-76.
2017
Kountouras, J., Kapetanakis N., Polyzos S. A., Katsinelos P., Gavalas E., Tzivras D., et al. (2017).  Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence.. Gut Liver. 11(5), 733-734.
Cohen, S. A., Yu M., Baker K., Redman M., Wu C., Heinzerling T. J., et al. (2017).  The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.. Clin Epigenetics. 9, 46.
Neofytou, K., Giakoustidis A., Neves M. Costa, Morrison D., Giakoustidis D., Khan A. Z., et al. (2017).  Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.. Langenbecks Arch Surg. 402(4), 599-605.
Kountouras, J., Polyzos S. A., Kapetanakis N., Katsinelos P., Nikolopoulos P., Stogianni A., et al. (2017).  Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia.. Aliment Pharmacol Ther. 45(4), 576-577.
T Kingham, P., Nguyen H. C. B., Zheng J., Konstantinidis I. T., Sadot E., Shia J., et al. (2017).  MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.. Oncotarget. 8(12), 18821-18831.
2016
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
Mogoanta, S. Stefanita, Calotă F., Vasile I., Crafciuc A. Valentina, Gherghinescu M. Constantin, Sapalidis K., et al. (2016).  Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations.. Rom J Morphol Embryol. 57(1), 65-74.
Karatzas, D. N., Xanthopoulos K., Kotantaki P., Pseftogas A., Teliousis K., Hatzivassiliou E. G., et al. (2016).  Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report.. Cell Oncol (Dordr). 39(3), 287-93.
Papadopoulos, V., Tsapakidis K., Del Galdo N. A. Riobo, Papandreou C. N., Del Galdo F., Anthoney A., et al. (2016).  The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer.. Clin Colorectal Cancer. 15(2), 116-27.
2015
Pentheroudakis, G., Raptou G., Kotoula V., Wirtz R. M., Vrettou E., Karavasilis V., et al. (2015).  Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.. PLoS One. 10(5), e0124612.
Pectasides, D., Karavasilis V., Papaxoinis G., Gourgioti G., Makatsoris T., Raptou G., et al. (2015).  Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or. BMC Cancer. 15, 384.
2014
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Kouklakis G., Venizelos I., et al. (2014).  Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence.. Scand J Gastroenterol. 49(3), 381-2.
Evrard, S., Poston G., Kissmeyer-Nielsen P., Diallo A., Desolneux G., Brouste V., et al. (2014).  Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.. PLoS One. 9(12), e114404.
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Dedemadi G., Goumas C., et al. (2014).  The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer.. Tumour Biol. 35(6), 5993-6002.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Romiopoulos, I., Kountouras J., Polyzos S. A., Zavos C., Kapetanakis N., Deretzi G., et al. (2014).  Helicobacter pylori-related metabolic syndrome might justify earlier colorectal cancer screening.. Gastrointest Endosc. 80(1), 188-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές